BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35411225)

  • 1. EPHB2 expression is associated with intestinal phenotype of gastric cancer and indicates better prognosis by suppressing gastric cancer migration.
    Kim H; Myung JK; Paik SS; Kim H; Park H; Kim YJ; Lee SB; Kim HU; Song HJ; Jeong IH; Hong S; Park CM; Lee C; Kim Y; Jang B
    Am J Cancer Res; 2022; 12(3):1295-1308. PubMed ID: 35411225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
    Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B
    Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion.
    Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG
    Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression Profile and Prognostic Significance of EPHB3 in Colorectal Cancer.
    Jang BG; Kim HS; Bae JM; Kim WH; Hyun CL; Kang GH
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32294981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphB2 represents an independent prognostic marker in patients with gastric cancer and promotes tumour cell aggressiveness.
    Yin J; Li Z; Ye L; Birkin E; Li L; Xu R; Chen G; Ji J; Zhang Z; Jiang WG; Cui Y
    J Cancer; 2020; 11(10):2778-2787. PubMed ID: 32226496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
    Jang BG; Lee BL; Kim WH
    Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
    Jang BG; Lee BL; Kim WH
    Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett's Esophagus.
    Jang BG; Lee BL; Kim WH
    PLoS One; 2015; 10(5):e0127300. PubMed ID: 25996368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
    Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
    Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers.
    Jang BG; Kim HS; Bae JM; Kim WH; Kim HU; Kang GH
    Sci Rep; 2020 Sep; 10(1):14591. PubMed ID: 32884102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
    Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
    World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of EPHB2 Expression in Colorectal Cancer Progression.
    Jang BG; Kim HS; Chang WY; Bae JM; Kang GH
    J Pathol Transl Med; 2018 Sep; 52(5):298-306. PubMed ID: 30016858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer.
    Ebrahim AS; Hailat Z; Bandyopadhyay S; Neill D; Kandouz M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of EphB2 is significantly associated with nodal metastasis in Chinese patients with gastric cancer.
    Yu G; Gao Y; Ni C; Chen Y; Pan J; Wang X; Ding Z; Wang J
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):73-80. PubMed ID: 20238226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of human kallikrein 12 gene expression in gastric cancer.
    Zhao EH; Shen ZY; Liu H; Jin X; Cao H
    World J Gastroenterol; 2012 Dec; 18(45):6597-604. PubMed ID: 23236234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of junctional adhesion molecule-A and EphB2 predicts poor survival in lung adenocarcinoma patients.
    Zhao C; Wang A; Lu F; Chen H; Fu P; Zhao X; Chen H
    Tumour Biol; 2017 Feb; 39(2):1010428317691000. PubMed ID: 28231727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of LGR5+ cells and associated implications during the early stage of gastric tumorigenesis.
    Jang BG; Lee BL; Kim WH
    PLoS One; 2013; 8(12):e82390. PubMed ID: 24340024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ephrin Receptor B2 Expression May Be a Prognostic Marker for Patients With Cancer: A Meta-analysis.
    Koh HM; Hyun CL; Jang BG; Lee HJ
    Anticancer Res; 2020 Aug; 40(8):4309-4317. PubMed ID: 32727758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications.
    Seno H; Oshima M; Taniguchi MA; Usami K; Ishikawa TO; Chiba T; Taketo MM
    Int J Oncol; 2002 Oct; 21(4):769-74. PubMed ID: 12239615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions.
    Qin R; Wang NN; Chu J; Wang X
    World J Gastroenterol; 2012 Jul; 18(25):3296-302. PubMed ID: 22783055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.